microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

Abstract Background One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict. One of the miRNAs kn...

Full description

Bibliographic Details
Main Authors: Sunyoung Park, Jungho Kim, Kiyoon Eom, Sehee Oh, Sunghyun Kim, Geehyuk Kim, Sungwoo Ahn, Kwang Hwa Park, Dawn Chung, Hyeyoung Lee
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cancer
Subjects:
microRNAs
Survival
Prognosis
Uterine cervical neoplasm
Online Access:http://link.springer.com/article/10.1186/s12885-019-5620-6

Internet

http://link.springer.com/article/10.1186/s12885-019-5620-6

Similar Items